CytoPherx, founded in July 2007 and headquartered in Ann Arbor, is a venture-backed, clinical stage medical device company addressing inflammation-based diseases and conditions with a proprietary selective cytopheresis system.
206 S 5th St
Suite 550
Ann Arbor, MI 48104